The European regulator said on Thursday that it had approved for the first time the marketing in the European Union of two antibody treatments against the coronavirus.
The European Medicines Agency (EMA) said in a statement that it had approved the use of a treatment from the Swiss pharmaceutical company Roche, Ronapreve, and a treatment from the South Korean company Celltrion, regdanvimab.